1/10 Review
et al., J. Control Release, doi:10.1016/j.jconrel.2020.10.009 (Review) (Peer Reviewed)
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
Review hypothesizing that micro- and nanotechnology-based formulations of ivermectin for the pulmonary delivery of ivermectin may be beneficial for use with COVID-19.
Formiga et al., 1/10/2021, peer-reviewed, 6 authors.
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.